ICON Web & News
Search Using OECD Database
Return to Previous Page
Addition or Correction
Handling Worker and Third-Party Exposures to Nanotherapeutics During Clinical Trials
Link to Journal Abstract
The article focuses on issues relating to occupational exposures of researchers and lab workers, and exposures of bystanders such as health care workers and family members during HSR using nanomaterials. Such third-party exposures give rise to unique challenges relating to oversight as well as exposures to worker groups not previously studied. Given the current state of knowledge regarding health risks from such exposures, a more precautionary approach to oversight seems advisable.
The article focuses on issues relating to occupational exposures of researchers and lab workers, and exposures of bystanders such as health care workers and family members during human subjects research (HSR) using nanomaterials.
Peer Reviewed Journal Article
Exposure Or Hazard Target
Method Of Study
Risk Exposure Group
The Journal of Law, Medicine & Ethics, 40(4): 856-864 (Winter 2012)
The Journal of Law, Medicine & Ethics
Ramachandran G, Howard J, Maynard A, Philbert M
Last updated on February 20, 2013
This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.
Why Join Us?
Mission and Strategy
Good Nano Guide
Nano EHS Research Needs
Current Practices Survey